KR101168566B1 - Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea - Google Patents

Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea Download PDF

Info

Publication number
KR101168566B1
KR101168566B1 KR1020100047540A KR20100047540A KR101168566B1 KR 101168566 B1 KR101168566 B1 KR 101168566B1 KR 1020100047540 A KR1020100047540 A KR 1020100047540A KR 20100047540 A KR20100047540 A KR 20100047540A KR 101168566 B1 KR101168566 B1 KR 101168566B1
Authority
KR
South Korea
Prior art keywords
plant disease
ethanol
water
mixed solvent
plant
Prior art date
Application number
KR1020100047540A
Other languages
Korean (ko)
Other versions
KR20110127980A (en
Inventor
정용환
김지현
함영민
이경후
오대주
강세찬
김윤정
송정민
최한
Original Assignee
재단법인 제주테크노파크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 재단법인 제주테크노파크 filed Critical 재단법인 제주테크노파크
Priority to KR1020100047540A priority Critical patent/KR101168566B1/en
Publication of KR20110127980A publication Critical patent/KR20110127980A/en
Application granted granted Critical
Publication of KR101168566B1 publication Critical patent/KR101168566B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N65/00Biocides, pest repellants or attractants, or plant growth regulators containing material from algae, lichens, bryophyta, multi-cellular fungi or plants, or extracts thereof
    • A01N65/08Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/12Powders or granules
    • A01N25/14Powders or granules wettable
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/24Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing ingredients to enhance the sticking of the active ingredients
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/04Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
    • A01N43/14Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
    • A01N43/16Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D11/00Solvent extraction
    • B01D11/02Solvent extraction of solids

Abstract

본 발명은 갯까치수영 추출물, 갯까치수영 추출물로부터 분리한 아나갈로사포닌 Ⅳ, 아나갈로사포닌 Ⅷ 또는 아나갈리신 C를 이용한 마그나포르테 그리세아에 의한 식물병 방제제 조성물과 마그나포르테 그리세아에 의한 식물병 방제 방법을 개시한다. 상기 갯까치수영 추출물과 아나갈로사포닌 Ⅳ, 아나갈로사포닌 Ⅷ 및 데스글루코나갈로시드 B는 모두 마그나포르테 그리세아에 대해서 항곰팡이 활성을 보인다.The present invention relates to a plant disease control composition and magnaporte griesae by Magnaporte grisea using Anagala saponin Ⅳ, Anagala saponin Ⅷ, or Anagalisin C isolated from the magpie swimming extract. A plant disease control method by the same is disclosed. The larvae extract, Anagalarosaponin IV, Anagalarosaponin VII, and Desglucoalogalside B all exhibit antifungal activity against Magnaporte greece.

Description

마그나포르테 그리세아에 의한 식물병 방제제 조성물 및 식물병 방제 방법{Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea}Composition and Method for Controlling Plant Disease Occurred by Magnaporthe grisea

본 발명은 마그나포르테 그리세아에 의한 식물병 방제제 조성물 및 식물병 방제 방법에 관한 것이다.
The present invention relates to a plant disease control composition and a plant disease control method by Magna Porte Grisse.

마그나포르테 그리세아(Magnaporthe grisea)는 도열병의 원인균으로서 진균계의 자낭균문에 속한다. 이 병원균은 분생포자의 형태로 월동한 후 비산하여 기주에 부착?침입함으로써 병반을 형성한다. 균사의 최적 발육 온도는 27~28℃이다. Magnaporthe grisea is a causative agent of fungal diseases and belongs to the fungal follicles. The pathogens overwinter in the form of conidia and then scatter and form a lesion by attaching and invading the host. Optimal growth temperature of the mycelia is 27 ~ 28 ℃.

마그나포르테 그리세아(Magnaporthe grisea)(불완전 세대의 학명은 Pyricularia grisea임)는 진균계의 자낭균문에 속하며, 주로 분생포자세대로 존재한다. 무색에 가까운 분생포자는 서양배 모양으로 2개의 격막을 가지고 있다. 병원균의 최적 균사 발육 온도는 27-28℃이다. 침입에 소요되는 시간은 24℃에서 6시간, 20℃와 28℃에서는 8시간 정도이다. Magnaporthe grisea ) (the name of the incomplete generation is Pyricularia grisea ) belongs to the asymptomatic fungus of the fungal system, and mainly exists as conidia. The colorless conidia are pear-shaped and have two diaphragms. Optimal mycelial growth temperature for pathogens is 27-28 ° C. The time required for intrusion is about 6 hours at 24 ° C and 8 hours at 20 ° C and 28 ° C.

이 병원균은 분생포자의 형태로 월동한 후 비산하여 기주에 부착?침입함으로써 병반을 형성한다. 비가 자주 오고 일조가 부족하여 냉냉하고 음습한 일기가 계속될 때, 토양의 온도가 낮고 토양수분 함량이 적으며 질소질 비료를 과용했을 때, 밀식재배로 통풍이 불량하고 이앙기가 늦었을 때 병 발생에 좋은 조건이 된다.The pathogens overwinter in the form of conidia and then scatter and form a lesion by attaching and invading the host. When there are frequent rains and lack of sunshine, cold and humid weather continues, when the soil temperature is low, the soil moisture content is low, and when nitrogen fertilizer is overused, the planting is poor when the planting is poorly ventilated and the rice transplanting season is late. It is a good condition.

마그나포르테 그리세아의 기주 식물은 벼, 잔디, 밀, 보리, 피 등의 벼과 식물이며, 대표적으로는 벼, 잔디이다.The host plants of Magna Forte Grissea are rice plants such as rice, grass, wheat, barley, and blood.

벼 도열병은 전 세계 벼를 재배하는 지역에서 벼의 생육 초기부터 후기에 이르기까지 모든 생육시기에 발생하여 큰 피해를 주는 병해이다(Leung & Taga, Advances in Pathology Genetic of Plant Pathogenic Fungi, pp. 175-188, 1988). 비가 자주 오고 일사량이 부족한 조건에서 병이 발생하는데, 피해 부위에 따라 잎 도열병, 이삭 도열병, 이삭가지 도열병, 벼알 도열병, 마디 도열병, 엽절 도열병 등으로 나눈다. 어린 모에 발생한 경우는 모 도열병이라 한다.Rice blast is a disease that causes great damage at all stages of growth from the early to late stages of rice production in the world where rice is grown (Leung & Taga, Advances in Pathology Genetic of Plant Pathogenic Fungi , pp. 175-). 188, 1988). The disease occurs under conditions of frequent rain and insolation, and according to the damage area, it is divided into leaf blast, ear blast, ear branch blast, rice blast, node blast, and leaf blast. The cases of young mothers are called fever.

잔디 도열병은 세인트어거스틴 그래스(St. Augustinegrass), 캔터키블루그래스(Kentucky bluegrass), 퍼레니얼 라이그래스(Perennial ryegrass), 톨 훼스큐(tall fescue)에 주로 발생되며, 간혹 한국잔디에도 발생되는 엽고병의 일종이다. 잔디 잎이나 줄기에 원형 혹은 타원형의 엷은 회색 병반이 형성되고 이들 병반이 겹쳐져서 잎 전체가 갈변하여 고사한다. 제주도 내 6개 골프장에 대한 18개 샘플조사에서 나타난 질병은 엽고병 25.87%. 달라스팟 20.69%. 잔디 도열병 19.28% 순으로 나타났다(제주환경일보 2009년 12월 14일자 기사). Turf blast is mainly caused by St. Augustinegrass, Kentucky bluegrass, Perennial ryegrass, and tall fescue, and sometimes occurs in Korean grass. It is a kind. Round or oval, pale gray lesions formed on the leaves or stems of grass, and these lesions overlap, causing the entire leaves to brown and die. In 18 samples of 6 golf courses in Jeju Island, 25.87% of the diseases were found. Dallas Spot 20.69%. Turf fever was found in 19.28% (Jeju Environment Daily December 14, 2009 article).

마그나포르테 그리세아에 의한 도열병 피해를 줄이기 위한 방법으로는 저항성 품종 이용, 시비량 조절, 채식 밀도 조절 등의 경종적 방제법, tricyclazol, Capropamid 등 화학 농약을 이용한 화학적 방제법, 그리고 방선균 등의 미생물 배양액(대한민국 공개특허 제2006-0019866호)이나 석류 껍질나 부추씨 등의 추출액(The Korean Journal of Mycology, 33(2): 86-88), 율금 추출액(대한민국 공개특허 제2006-0039954호) 등을 이용한 생물학적 방제법으로 대별할 수 있다.Methods to reduce the blast damage caused by Magna Forte Grisse include the use of resistant varieties, fertilization control, seedling control such as vegetarian density control, chemical control using chemical pesticides such as tricyclazol and Capropamid, and microbial culture such as actinomycetes. Patent No. 2006-0019866), extracts such as pomegranate peel or leek seed ( The Korean Journal of Mycology , 33 (2): 86-88), rate control (Korean Patent Publication No. 2006-0039954), etc. It can be divided into.

본 발명도 생물학적 방제법을 제시한다.
The present invention also provides a biological control method.

본 발명의 목적은 갯까치수영(Lysimachia mauritiana Lamack) 추출물과 그 추출물에서 분리한 활성물질을 이용한 마그나포르테 그리세아에 의한 식물병 방제제 조성물을 제공하는 데 있다.An object of the present invention is Conger blackcurrant swimming (Lysimachia mauritiana Lamack) to provide a plant disease control agent composition according to Magna Forte so years old child with active substance isolated from the extract and the extract.

본 발명의 다른 목적은 상기 조성물을 이용한 마그나포르테 그리세아에 의한식물병의 방제 방법을 제공하는 데 있다.
Another object of the present invention is to provide a method for controlling a plant disease by Magna Porte Grisse using the composition.

본 발명은 갯까치수영(전초)의 80% 에탄올 추출물, 그 추출물의 부탄올 등의 분획물 그리고 그 분획물로부터 분리한 단일물질인 세 가지의 활성물질이 벼 도열병 등의 병원균인 마그나포르테 그리세아에 대해서 항곰팡이 활성을 가짐을 확인함으로써 완성된 것이다. The present invention is directed against 80% ethanol extracts of magnolias (outposts), fractions such as butanol and the like, and three active substances isolated from the fractions against magnaporte grisea, a pathogen such as rice blast. It is completed by confirming having fungal activity.

상기 세 가지 활성물질은 각각 아나갈로사포닌 Ⅳ(Anagallosaponin Ⅳ), 아나갈로사포닌 Ⅷ(Anagallosaponin Ⅷ) 및 아나갈리신 C(Anagallisin C)로서 모두 공지의 물질이며(Chem Pharm Bull . 42(9):1750-5, 1994; Phytochemistry . 37(5):1397-402, 1994; Journal of Asian Natural Products Research, 10, 265-270, 2008; Journal of Natural Products, 58(10): 1492?1497, 1995; CAS No.:162763-02-2(Anagallosaponin Ⅳ); CAS No.:160632-43-9(Anagallosaponin Ⅷ), CAS No.: 114318-84-2(Anagallisin C)), 그 화학식은 아래의 [화학식 1 내지 3]에서 확인할 수 있다. 상기 세 가지 물질은 아래의 실시예에 제시된 방법에 따라 갯까치수영으로부터 분리하거나, 이들 물질을 포함하는 것으로 알려진 뚜껑별꽃(Anagallis arvensis L.)(Noburu 등, Chem Pharm Bull . 42(9):1750-5, 1994), 까치수영속 식물인 리시마치아 크리스티내(Lysimachia christinae) (Tian 등, Journal of Asian Natural Products Research, 10, 265-270, 2008), 자금우과 식물인 미르신 아우스트랄리스(Myrsine australis) (Hegde 등, Journal of Natural Products, 58(10): 1492~1497, 1995) 등으로부터 상기 문헌에 개시된 분리 방법에 따라 분리할 수 있다. 상기 인용한 문헌은 모두 본 명세서의 일부로서 간주 된다.The three active substances are anagallosaponin IV and angallosaponin IV, respectively.(Anagallosaponin iii) and Anagallisin C, both known substances (Chem Pharm Bull . 42 (9): 1750-5, 1994;Phytochemistry . 37 (5): 1397-402, 1994;Journal of Asian Natural Products Research, 10, 265-270, 2008;Journal of Natural Products58 (10): 1492-1497, 1995; CAS No.:162763-02-2 (Anagallosaponin IV); CAS No .: 160632-43-9 (Anagallosaponin VII), CAS No .: 114318-84-2 (Anagallisin C)), and the chemical formula thereof can be found in the following [Formulas 1 to 3]. The three materials are separated from the magpie swimming, or are known to contain these materials according to the methods set forth in the Examples below.Anagallis arvensis L.) (Noburu et al.,Chem Pharm Bull . 42 (9): 1750-5, 1994), Rishimacia CristinaLysimachia christinae) (Tian et al., Journal of Asian Natural Products Research, 10, 265-270, 2008), Myrtle Australis, the Forbidden Plant (Myrsine australis(Hegde et al.,Journal of Natural Products, 58 (10): 1492-1497, 1995) and the like. All documents cited above are considered to be part of this specification.

(화학식 1)(Formula 1)

아나갈로사포닌 ⅣAnagalrosaponin Ⅳ

Figure 112010032577425-pat00001
Figure 112010032577425-pat00001

(화학식 2)(Formula 2)

아나갈로사포닌 ⅧAnagalrosaponin Ⅷ

Figure 112010032577425-pat00002
Figure 112010032577425-pat00002

(화학식 3)(Formula 3)

아나갈리신 CAnagallysin C

Figure 112010032577425-pat00003
Figure 112010032577425-pat00003

전술한 바를 고려할 때, 본 발명의 방제제 조성물은 갯까치수영 추출물, 갯까치수영 추출물의 분획물, 아나갈로사포닌 Ⅳ, 아나갈로사포닌 Ⅷ 또는 아나갈라신 C를 유효성분으로 포함함을 특징으로 한다. In view of the foregoing, the control agent composition of the present invention is characterized by comprising a magpie swimming extract, a fraction of a magpie swimming extract, an gallo saponin IV, an gallo saponin Ⅷ or an agalagasin C as an active ingredient. do.

본 명세서에서, 상기 "유효성분"의 의미는 단독으로 목적하는 활성을 나타내거나 또는 그 자체는 활성이 없는 담체와 함께 활성을 나타낼 수 있는 성분을 의미한다.In the present specification, the term "active ingredient" means a component that can exhibit activity alone or in combination with a carrier which is not active in itself.

또한 본 명세서에서, "갯까치수영 추출물"은 추출 방법을 불문하고 추출 대상인 갯까치수영의 전초(全草), 줄기, 잎, 뿌리, 열매, 종자 및/또는 꽃을 메탄올, 에탄올, 부탄올 등의 탄소수 1 내지 5의 저급 알콜, 아세톤, 헥산, 에틸아세테이트, 디클로로메탄, 물 또는 이들의 혼합 용매로 추출하여 얻어진 추출물을 의미한다. 추출 방법을 불문하므로, 추출 대상을 추출 용매에 침지시키는 단계를 통하여 추출되는 한, 추출 방법은 냉침, 환류, 가온, 초음파 방사 등 임의의 방식이 모두 적용될 수 있는 것으로 이해되어야 한다. 그럼에도 상기 "갯까치수영 추출물"은 바람직하게는 물, 에탄올 또는 이들의 혼합 용매, 더 바람직하게는 물과 에탄올의 혼합 용매, 특히 70~90%의 에탄올로 추출하고 얻어진 추출물을 의미한다(본 명세서에서 %는 부피%를 의미한다. 이하 같다). 추출물은 여과, 농축될 수 있으며 성상은 액상 또는 분말상일 수 있다. In addition, in the present specification, "scatfish swimming extract" refers to the extracts, stems, leaves, roots, fruits, seeds and / or flowers of the magpie swimming, which are to be extracted regardless of the extraction method, such as methanol, ethanol, butanol, etc. It means an extract obtained by extraction with a lower alcohol having 1 to 5 carbon atoms, acetone, hexane, ethyl acetate, dichloromethane, water or a mixed solvent thereof. Regardless of the extraction method, it is to be understood that the extraction method may be applied to any method such as cooling, refluxing, heating, ultrasonic radiation, and the like, as long as the extraction object is extracted through immersion in the extraction solvent. Nevertheless, the "squash swim extract" preferably means an extract obtained by extracting with water, ethanol or a mixed solvent thereof, more preferably a mixed solvent of water and ethanol, in particular 70-90% of ethanol. In% means volume%, which is the same below). The extract may be filtered, concentrated and the phase may be liquid or powder.

또한 본 명세서에서, "갯까치수영 추출물의 분획물"은 상기 갯까치수영 추출물, 바람직하게는 물과 에탄올의 혼합 용매, 특히 70~90%의 에탄올로 얻어진 갯까치수영 추출물을 메탄올과 물의 혼합 용매 특히 10~40% 메탄올에 현탁시킨 후, 부탄올 또는 헥산으로 분획하여 얻어진 어느 한 용매층의 분획물을 의미하며, 나아가 상기 갯까치수영 추출물을 메탄올과 물의 혼합 용매 특히 10~40% 메탄올에 현탁시킨 후, 헥산, 디클로로메탄, 에틸아세테이트 및 부탄올을 이용하여 순차적으로 분획하여 얻어진 추출물을 의미한다. 여기서 "순차적으로 분획한다"는 것의 의미는 물과 메탄올층의 분획물을 분획 후에도 계속 사용하여 상기 열거된 순서의 용매로 분획한다는 의미이다.In addition, in the present specification, "a fraction of magpie swimming extract" refers to a magnolia swimming extract, preferably a mixed solvent of water and ethanol, in particular a magpie swimming extract obtained from 70 to 90% ethanol, in particular a mixed solvent of methanol and water Suspended in 10-40% methanol, which means a fraction of a solvent layer obtained by fractionation with butanol or hexane, and further, after the suspension of the magpie swimming extract is suspended in a mixed solvent of methanol and water, in particular 10-40% methanol, Means an extract obtained by sequentially fractionating with hexane, dichloromethane, ethyl acetate and butanol. By "sequentially fractionating" here is meant that fractions of water and methanol layer continue to be used after fractionation with solvents in the order listed above.

또한 본 명세서에서, "방제"는 마그나포르테 그리세아에 의한 식물병의 예방, 치료 또는 증상의 완화를 의미한다.In addition, in this specification, "control" means the prevention, treatment or alleviation of symptoms of plant diseases caused by Magna Porte Grisse.

또한 본 명세서에서, "마그나포르테 그리세아에 의한 식물병"은 벼 도열병과 잔디 도열병을 포함하는 의미이며, 보리, 밀, 피 등도 마그나포르테 그리세아의 기주식물이므로 이들 식물의 도열병도 포함하는 의미이다. In addition, in the present specification, "plant diseases caused by Magna Forte Grisse" means a rice blast and grass blast, and barley, wheat, blood and the like are also host plants of Magna Porte grisea, meaning that they also include blasts of these plants. .

본 발명의 방제제 조성물은 그 유효성분들을 본 발명의 방제제 조성물 전체 중량을 기준으로 그것의 제형, 적용되는 대상?부위 등에 따라 1 내지 99 중량%의 범위 내에서 임의의 양으로 포함될 수 있는데, 통상적으로는 1 내지 30 중량%의 범위로 포함될 것이며, 액제에서는 통상 10 내지 20 중량%, 분제에서는 통상 30 내지 40 중량% 범위로 포함될 것이다.The control agent composition of the present invention may be included in any amount within the range of 1 to 99% by weight of the active ingredients, depending on its formulation, the subject to be applied, etc., based on the total weight of the control agent composition of the present invention, It will typically be included in the range of 1 to 30% by weight, usually in the range of 10 to 20% by weight in liquids, and typically in the range of 30 to 40% by weight in powders.

본 발명의 방제제 조성물은 유효성분들의 제형 그대로 제조되거나, 농약학적으로 허용 가능한 담체와 혼합되어 유제, 용액제, 현탁제, 수화제, 유동제, 분제, 과립제, 분산제 등으로 제형화될 수 있다. The control composition of the present invention may be prepared as a formulation of the active ingredients, or may be mixed with an agriculturally acceptable carrier to be formulated into an emulsion, solution, suspension, hydrating agent, flow agent, powder, granule, dispersant, and the like.

상기에서 "농약학적으로 수용 가능한 담체"는 본 발명의 방제제 조성물의 유효성분과 배합되어 그 유효성분의 활성을 저해하지 않으면서 그 유효성분의 살포, 저장 및/또는 운반을 촉진시키고 식물에 허용 가능한 이상의 독성을 나타내지 않는 임의의 물질을 말한다. In the above, the "agrochemically acceptable carrier" is combined with the active ingredient of the control agent composition of the present invention to promote the spreading, storage and / or transport of the active ingredient without inhibiting the activity of the active ingredient and acceptable to plants It refers to any substance that does not exhibit the above toxicity.

사용될 수 있는 담체는 토양 천연 광물(예를 들면 카올린, 점토, 활석, 초크), 토양 합성 광물(예를 들면 고분산 실리카, 실리케이트), 탄소 기재 물질(목탄, 역청 등), 황, 천연 또는 합성 수지, 비료, 셀룰로스 기재 물질(톱밥 및 옥수수 속대), 물, 방향족 용매(예: 솔베소 프로덕츠, 자일렌), 파라핀(예를 들면 광유 분획), 알코올(예를 들면 메탄올, 부탄올, 펜탄올, 벤질 알코올), 케톤(예를 들면 시클로헥사논, 메틸 히드록시부틸 케톤, 디아세톤 알코올, 메시틸 옥사이드, 이소포론), 락톤(예를 들면 감마-부티로락톤), 피롤리돈(피롤리돈, N-메틸피롤리돈, N-에틸피롤리돈, n-옥틸피롤리돈), 아세테이트(글리콜 디아세테이트), 글리콜, 디메틸 지방산 아미드, 지방산, 지방산 에스테르, 및 이들의 혼합물을 포함한다.Carriers that can be used are soil natural minerals (e.g. kaolin, clay, talc, chalk), soil synthetic minerals (e.g. highly dispersed silica, silicate), carbon based materials (charcoal, bitumen, etc.), sulfur, natural or synthetic Resins, fertilizers, cellulose based materials (sawdust and corncobs), water, aromatic solvents (e.g. Solvesso products, xylene), paraffins (e.g. mineral oil fractions), alcohols (e.g. methanol, butanol, pentanol, Benzyl alcohol), ketones (e.g. cyclohexanone, methyl hydroxybutyl ketone, diacetone alcohol, mesityl oxide, isophorone), lactones (e.g. gamma-butyrolactone), pyrrolidone (pyrrolidone) , N-methylpyrrolidone, N-ethylpyrrolidone, n-octylpyrrolidone), acetates (glycol diacetate), glycols, dimethyl fatty acid amides, fatty acids, fatty acid esters, and mixtures thereof.

본 발명의 방제제 조성물은 또한 습윤제, 분산제, 부동제, 증점제, 보존제, 전착제 등 하나 이상의 보조제를 포함할 수 있다.The control composition of the present invention may also include one or more adjuvants such as wetting agents, dispersants, antifreezes, thickeners, preservatives, electrodeposition agents.

이러한 보조제는 당업계에서 공지된 것들 중에서 적절한 것을 선택하여 사용할 수 있는데, 예컨대 습윤제로서는 알킬나프탈렌 술포네이트(특히 디이소프로필나프탈렌술포네이트 또는 디이소부틸나프탈렌술포네이트)를 사용할 수 있고, 분산제로서는 비이온성 분산제(에틸렌 옥사이드/프로필렌 옥사이드 블록중합체, 알킬페놀 폴리글리콜 에테르, 트리스티릴페놀 폴리글리콜 등), 음이온성 분산제(리그닌술폰산, 나프탈렌술폰산, 페놀술폰산, 디부틸나프탈렌술폰산, 알킬아릴술포네이트, 알킬 술페이트, 알킬술포네이트 등) 또는 이들의 혼합물을 사용할 수 있으며, 부동제로서는 메탄올, 에탄올, 이소프로판올, 부탄올, 글리콜, 글리세린, 디에틸렌글리콜 등을 사용할 수 있고, 증점제로서는 셀룰로즈 유도체, 폴리아크릴산 유도체, 잔탄, 개질된 점토 등을 사용할 수 있으며, 보존제로서는 디클로로펜, 이소티아졸렌, 벤질 알코올 등을 사용할 수 있으며, 전착제는 폴리비닐알코올, 폴리비닐피롤리돈, 폴리아크릴레이트, 폴리메타크릴레이트, 폴리부텐, 폴리이소부틸렌, 폴리스티렌, 폴리에틸렌아민, 폴리에틸렌아미드, 폴리에틸렌이민, 폴리에테르 등을 사용할 수 있다.Such adjuvants may be selected and used appropriately from those known in the art, for example, alkylnaphthalene sulfonate (particularly diisopropylnaphthalenesulfonate or diisobutylnaphthalenesulfonate) may be used as the wetting agent, and nonionic as a dispersant. Dispersants (ethylene oxide / propylene oxide block polymers, alkylphenol polyglycol ethers, tristyrylphenol polyglycols, etc.), anionic dispersants (ligninsulfonic acid, naphthalenesulfonic acid, phenolsulfonic acid, dibutylnaphthalenesulfonic acid, alkylarylsulfonates, alkyl sulfides) Pate, alkylsulfonate, etc.) or mixtures thereof, methanol, ethanol, isopropanol, butanol, glycol, glycerin, diethylene glycol and the like can be used, and as a thickener, cellulose derivatives, polyacrylic acid derivatives, xanthan Modified clay As the preservative, dichlorophene, isothiazolene, benzyl alcohol, etc. can be used, and the electrodeposition agent is polyvinyl alcohol, polyvinylpyrrolidone, polyacrylate, polymethacrylate, polybutene, polyisobutylene , Polystyrene, polyethyleneamine, polyethyleneamide, polyethyleneimine, polyether and the like can be used.

본 발명의 방제제 조성물은 사용 목적, 경작지의 환경 등에 따라 추가로 기타의 공지의 성분, 예컨대 제초성 성분, 살충성 성분, 살균성 성분 등을 포함할 수 있다.The control composition of the present invention may further contain other known components such as herbicide components, insecticidal components, bactericidal components, etc., depending on the purpose of use, the environment of the arable land, and the like.

다른 측면에 있어서, 본 발명은 전술한 바의 본 발명의 방제제 조성물을 이용한 마그나포르테 그리세아에 의한 식물병 방제 방법에 관한 것이다.In another aspect, the present invention relates to a method for controlling plant diseases by Magna Porte Grisea using the control composition of the present invention as described above.

본 발명의 마그나포르테 그리세아에 의한 식물병 방제 방법은 본 발명의 방제제 조성물을 벼, 잔디, 보리, 밀 등 식물체에 접촉시키는 단계를 포함함을 특징으로 한다.The method for controlling plant diseases by Magnaporte Grissea of the present invention is characterized by comprising the step of contacting the plant composition of the present invention, such as rice, grass, barley, wheat.

상기 접촉시키는 단계는 통상적으로 발병이 된 벼, 잔디, 보리, 밀에 살포함으로써 이루어질 것이나, 벼, 잔디 등의 서식 환경인 토양에 살포 또는 혼입함에 의해서 이루어지거나 또는 이들의 종자 또는 묘종에 살포하거나 그것의 서식 환경인 생장 배지 또는 토양에 살포 또는 혼합함에 의해서 이루어질 수도 있다.The contacting step will usually be achieved by spraying on the affected rice, grass, barley, wheat, or by spraying or incorporating into soil, which is the habitat environment of rice, grass, or the like, or by spraying the seeds or seedlings thereof It may also be achieved by spraying or mixing the growth medium or soil, which is the habitat environment for

또는 상기 접촉시키는 단계는 살균제, 살충제, 제초제, 비료 등과 혼합하여 이루어질 수도 있다. Alternatively, the step of contacting may be made by mixing with a fungicide, insecticide, herbicide, fertilizer and the like.

벼, 잔디 등의 식물체에 본 발명의 방제제의 유효성분을 어느 정도의 양으로 사용할 것인가는 벼, 잔디 등의 생육 정도, 병해 정도, 토양의 조건, 강우량, 사용할 유효성분의 종류 등을 종합적으로 고려하여 결정될 것이다. 통상은 헥타르 당 10 내지 500g, 바람직하게는 30 내지 250g으로 사용하고, 토양에 살포?혼합할 경우는 10 내지 1000g, 바람직하게는 100 내지 500g으로 사용한다.
The amount of the active ingredient of the present invention's control agent in plants such as rice and grass is comprehensively determined by the extent of growth of rice, grass, etc., degree of disease, soil conditions, rainfall, types of active ingredients to be used, and the like. Will be taken into account. Usually, 10 to 500 g, preferably 30 to 250 g per hectare, and 10 to 1000 g, preferably 100 to 500 g when spraying and mixing the soil.

전술한 바와 같이, 본 발명에 따르면, 갯까치수영 추출물과 그 추출물에서 분리한 활성물질을 이용한 마그나포르테 그리세아에 의한 식물병 방제제 조성물과 그 조성물을 이용한 마그나포르테 그리세아에 의한 식물병 방제 방법을 제공할 수 있다.
As described above, according to the present invention, the plant disease control agent composition by Magna Porte Grissa using the magpie swimming extract and the active substance isolated from the extract and the plant disease control method by Magna porte Grissa using the composition Can be provided.

도 1은 갯까치수영 80% 에탄올 추출물의 마그나포르테 그리세아에 대한 항곰팡이 활성 평가 결과이다.
도 2는 갯까치수영 각 분획물의 마그나포르테 그리세아에 대한 항곰팡이 활성의 평가 결과이다.
도 3에 갯까치수영 분획물 중 부탄올 분획물에서 역상실리카겔 칼럼크로마토그래피와 순상실리카겔 칼럼크로마토그래피를 실시하여 수득한 4번, 7번 및 8번 정제물의 마그나포르테 그리세아에 대한 항곰팡이 활성 실험 결과이다.
도 4는 활성물질의 분리 과정을 모식도이다.
도 5는 4번 정제물(아나갈로사포닌 Ⅳ)의 1H NMR 스펙트럼이다.
도 6은 4번 정제물(아나갈로사포닌 Ⅳ)의 13C NMR 스펙트럼 및 DEPT 스펙트럼이다.
도 7은 4번 정제물(아나갈로사포닌 Ⅳ)의 LC-MS/MS 스펙트럼이다.
도 8은 7번 정제물(아나갈로사포닌 Ⅷ)의 1H NMR 스펙트럼이다.
도 9는 7번 정제물(아나갈로사포닌 Ⅷ)의 13C NMR 스펙트럼이다.
도 10은 7번 정제물(아나갈로사포닌 Ⅷ)의 LC-MS/MS 스펙트럼이다.
도 11은 8번 정제물(아나갈리신 C)의 1H NMR 스펙트럼이다.
도 12는 8번 정제물(아나갈리신 C)의 13C NMR이다.
도 13은 8번 정제물(아나갈리신 C)의 LC-MS/MS 스펙트럼이다.
Figure 1 shows the results of antifungal activity evaluation of Magnaporte grisea of the magpies 80% ethanol extract.
FIG. 2 shows the results of evaluation of antifungal activity against Magnaporte griesea in each fraction of magpies.
Fig. 3 shows the results of antifungal activity test against Magna Porte Grisea from No. 4, No. 7, and No. 8 purified silica obtained by performing reverse phase silica gel column chromatography and normal phase silica gel column chromatography in butanol fractions.
Figure 4 is a schematic diagram of the separation process of the active material.
FIG. 5 is the 1 H NMR spectrum of Purification No. 4 (Angalalosaponin IV). FIG.
FIG. 6 is a 13C NMR spectrum and a DEPT spectrum of Purification No. 4 (Anagalosaponin IV). FIG.
FIG. 7 is an LC-MS / MS spectrum of Purification No. 4 (Anagalosaponin IV). FIG.
FIG. 8 is a 1 H NMR spectrum of Purification No. 7 (Anagalosaponin VII). FIG.
Figure 9 is a 13C NMR spectrum of Purification No. 7 (Analogalasponin VII).
FIG. 10 is an LC-MS / MS spectrum of Purification No. 7 (Anagalosaponin VII). FIG.
FIG. 11 is the 1H NMR spectrum of the eighth purified product (anagallysin C).
FIG. 12 is 13 C NMR of Purification No. 8 (Anagalizin C). FIG.
FIG. 13 is an LC-MS / MS spectrum of Purification No. 8 (anagallysin C). FIG.

이하 본 발명을 실시예를 참조하여 설명한다. 그러나 본 발명의 범위가 이러한 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described with reference to Examples. However, the scope of the present invention is not limited to these examples.

<실시예 1> 갯까치수영 추출물과 분획물의 제조 <Example 1> Preparation of Conger swimming blackcurrant extract and fractions

세절한 갯가치수영(전초) 1kg을 80% 에탄올에 넣고 48시간 동안 침지시켜 3회 반복 추출한 후 여과하여 얻어진 추출액을 감압 농축하여 용매를 제거하고 동결건조하여 분말상의 추출물 275g(27.5%)을 얻었다. 1 kg of fine valued swimming (outpost) was added to 80% ethanol, immersed for 48 hours, extracted three times, and the extract was filtered under reduced pressure to remove the solvent and freeze-dried to give 275 g (27.5%) of a powdery extract. .

그리고 상기 얻어진 에탄올 추출물 275g을 100배량의 20% 메탄올로 현탁 및 용해시킨 후에 헥산(n-hexane), 디클로로메탄(CH2Cl2), 에틸아세테이트(EtOAc) 및 부탄올(BuOH)로 순차적으로 분획하여 헥산층에서 8.35g(3.0%), 디클로로메탄층에서 9.01g(3.3%), 에틸아세테이트층에서 18.72g(6.8%), 부탄올층에서 82.42g(29.9%) 및 잔여 물층에서 115.03g(41.8%)의 분획물을 얻었다.Then, 275 g of the obtained ethanol extract was suspended and dissolved in 100-fold 20% methanol, and then sequentially partitioned into hexane (n-hexane), dichloromethane (CH 2 Cl 2 ), ethyl acetate (EtOAc) and butanol (BuOH). 8.35 g (3.0%) in hexane layer, 9.01 g (3.3%) in dichloromethane layer, 18.72 g (6.8%) in ethyl acetate layer, 82.42 g (29.9%) in butanol layer and 115.03 g (41.8%) in residual water layer Fractions).

<실시예 2> 갯까치수영 추출물과 분획물의 벼 도열병 곰팡이인 마그나포르테 그리세아에 대한 항곰팡이 활성 평가 <Example 2> Conger blackcurrant Antifungal activity evaluation of the Magna Forte years old child so the rice blast fungi in swimming extracts and fractions

<실시예 2-1> 갯까치수영 80% 에탄올 추출물의 항곰팡이 활성 평가 <Example 2-1> Conger blackcurrant swimming evaluate antifungal activity of the 80% ethanol extract

갯까치수영 80% 에탄올 추출물의 곰팡이에 대한 균사체 형성 억제능력을 평가하기 위하여, 벼 도열병 곰팡이인 마그나포르테 그리세아를 감자한천배지(PDA, potato dextrose agar) 상에서 5일간 배양 후 균총들의 가장자리에서 직경 6mm의 균사절편을 채취하여 갯까치수영 추출물이 1mg/mL의 농도로 첨가된 감자한천 배지에 접종하고 27℃에서 30일간 배양하여 균총의 생성을 측정하였다. In order to evaluate the mycelial formation-inhibiting ability of fungi in 80% ethanol extracts, the rice bran fungus Magnaforte greece is cultured on potato agar medium (PDA) for 5 days and 6mm in diameter at the edges of the mycelia. Mycelial slices were harvested and inoculated on potato agar medium supplemented with 1 mg / mL of Shrike Swimmer extract and incubated at 27 ° C. for 30 days.

그 결과를 도 1에 나타내었는데, 갯까치수영 추출물은 접종 후 15일까지는 전혀 균사가 생장하지 않았으나, 20일 경과 후부터 조금씩 형성되기 시작하였으나 30일 경과 후에도 85% 이상의 억제효과를 관찰할 수 있었다.The results are shown in Figure 1, the mylar swimming extract did not grow mycelia at all until 15 days after inoculation, but began to form a little after 20 days, but more than 85% of the inhibitory effect was observed after 30 days.

<실시예 2-2> 갯까치수영 분획물의 항곰팡이 활성 평가 <Example 2-2> Conger Magpie swimming Fraction Antifungal Activity Assessment

갯까치수영 추출물 중 분획물의 항곰팡이에 대한 균사체 형성 억제능력을 평가하기 위하여, 벼도열병(M. grisea) 곰팡이를 감자한천배지(PDA, potato dextrose agar) 상에서 5일간 배양 후 균총들의 가장자리에서 직경 6mm의 균사절편을 채취하여 각각 50 mg/mL 농도의 갯까치수영 분획물 40uL를 직경이 6mm인 paper disk에 떨어뜨린 후, 감자한천 배지에 접종하고 27℃에서 7일간 배양하여 균총의 생성을 측정하였다. In order to evaluate the mycelial formation inhibitory ability against antifungal activity of fractions in Sagefish extract, M. grisea fungus was cultured for 5 days on potato dextrose agar (PDA) and 6mm in diameter at the edges of mycelia. Mycelial slices were collected and dropped into 40 μL of 50 mg / mL saponica swimming fractions, respectively, on 6 mm diameter paper disks, inoculated in potato agar medium, and cultured at 27 ° C. for 7 days to determine the production of mycelia.

그 결과를 도 2에 나타내었는데, 갯까치수영 분획물 중 헥산 및 부탄올 분획물이 항곰팡이 활성을 보이고 있으나 부탄올 분획물에서 80% 에탄올 추출물 대비 가장 뛰어난 항곰팡이 활성이 관찰되었다(1과 5, (-) control; 2, 물 분획물; 3, 80% 에탄올추출물; 4, 부탄올 분획물; 6, 에틸아세테이트 분획물; 7, 디클로로메탄 분획물; 8, 헥산 분획물). The results are shown in Figure 2, but the hexane and butanol fractions of the Swallowtail fractions showed antifungal activity, but the superior antifungal activity was observed in the butanol fraction compared to 80% ethanol extract (1 and 5, (-) control). 2, water fraction; 3, 80% ethanol extract; 4, butanol fraction; 6, ethyl acetate fraction; 7, dichloromethane fraction; 8, hexane fraction).

<실시예 3> 갯까치수영 분획물 중 유효성분 분리?정제 및 벼 도열병 곰팡이인 마그나포르테 그리세아에 대한 항곰팡이 활성 평가 <Example 3> Slaughterhouse Swimming Separation of the active ingredient fractions? Purification and the rice blast fungus Magna Forte Evaluation of antifungal activity against greece

상기 <실시예 2-2>에서 가장 높은 항곰팡이 활성을 보이는 부탄올 분획물 12g을 역상실리카겔을 이용해 컬럼크로마토그래피를 실시하여 총 10개의 정제물을 얻었다. 컬럼의 크기는 7cm X 20cm 이며 20, 40, 60, 80, 100% 메탄올을 이동상으로 사용하였다. 10개의 정제물에 대해서 상기 <실시예 2-2>와 동일한 방법으로 (확인 바랍니다) 항곰팡이 활성을 평가하였을 때, 그 중 9번(G-B-9)의 정제물의 항곰팡이 활성이 우수하여 9번 정제물 1.1g에 대해 순상실리카겔 컬럼크로마토그래피를 실시하였다. 컬럼의 크기는 2.5cm X 50cm 이며 클로로포름:메탄올(1:1, v/v)을 이동상으로 사용하였다. 분당 1.5ml의 속도로 이동상을 흘려주었으며 총 8개의 정제물을 얻었다.12 g of butanol fraction showing the highest antifungal activity in <Example 2-2> was subjected to column chromatography using reverse phase silica gel to obtain a total of 10 purified products. The column size was 7 cm × 20 cm and 20, 40, 60, 80, 100% methanol was used as the mobile phase. When the antifungal activity of the 10 purified products was evaluated in the same manner as in <Example 2-2> (please confirm) , 9 (GB-9) of the purified products had excellent antifungal activity. Pure silica gel column chromatography was performed on 1.1 g of the purified product. The column size was 2.5 cm × 50 cm and chloroform: methanol (1: 1, v / v) was used as the mobile phase. The mobile phase was flowed at a rate of 1.5 ml per minute and a total of eight tablets were obtained.

상기 총 8개의 정제물에 대해서도 마찬가지로 상기 <실시예 2-2>와 동일한 방법으로 항곰팡이 활성을 평가하였는데, 4번(G-B-9-4, 137mg), 7번(G-B-9-7, 89mg) 및 8번(G-B-9-8, 114mg) 정제물의 활성이 가장 높게 나타났다. 도 3에 4번, 7번 및 8번 정제물의 항곰팡이 활성 실험의 결과를 나타내었다. Similarly, the antifungal activity was evaluated in the same manner as in <Example 2-2> with respect to the total eight purified products. ) And 8 (GB-9-8, 114 mg) tablets showed the highest activity. Figure 3 shows the results of the antifungal activity test of the 4th, 7th and 8th purification.

상기 4번, 7번 및 8번 정제물을 TLC(실리카겔 60 F 254 , 클로로포름;메탄올=1:1, v/v)에 전개했을 때 Rf는 각각 0.6, 0.3, 0.28이며 단일 스팟으로 나타났다. 도 4에 활성물질의 분리 과정을 모식도로 나타내었다. When the 4th, 7th and 8th purifications were developed on TLC (silica gel 60 F 254, chloroform; methanol = 1: 1, v / v), the Rf was 0.6, 0.3, 0.28 and showed a single spot, respectively. 4 is a schematic diagram showing the separation process of the active material.

<실시예 4> 활성물질의 동정 Example 4 Identification of Active Material

<실시예 4-1> 4번 정제물(G-B-9-4)의 활성물질 동정 - 아나갈로사포닌 Example 4-1 Identification of the Active Substance in Purified Product No. 4 (GB-9-4) -Anagalrosaponin IV

분리된 활성물질의 구조를 분석하기 위해 4번 정제물 20mg을 메탄올-d4에 녹여 NMR spectrum을 측정하였다. 1H NMR 스펙트럼(도 5)에서 8개의 메틸기를 확인했으며 그 중 하나는 아세틸기에 연결된 메틸기(δ 2.1ppm ,s)임을 확인했다. 또한 5-3.0ppm 부근의 시그널들로 미루어 배당체 형태임을 예상하였다. 13C NMR 스펙트럼(도 6)에서 아세틸기의 카르보닐 탄소 172.6ppm을 확인하였고 107.3, 105.6, 104.8, 104.3에서 당 4개의 아노머탄소들로 미루어 4개의 당이 배당체로 붙어 있음을 예상하여 문헌(Phytotherapy research, 12, s70-s73, 1998)과 13C NMR chemical shift를 비교한 결과 -O-[β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→4)]-[O-β-D-glucopyranosyl-(1→2)]-O-α-L-arabinopyranosyl 형태의 배당체임을 확인하였다. 또한 DEPT 스펙트럼(도 6)에서 8개의 4차 탄소, 24개의 CH, 14개의 CH2, 8개의 CH3를 확인하여 화함물의 총 탄소수는 54임을 알 수 있었다. 화합물 총탄소수에서 4개당의 탄소수를 제외했을 때 32개의 탄소수를 갖는 아글리콘의 구조는 아세틸 그룹이 결합하고 5환으로 구성된 triterpenoid 형태로 예상하였다. 또한 77.5ppm의 시그널이 CH2 임에도 저자장으로 많이 이동한 것으로 보아 링 내에 산소가 결합된 epoxy 형태임을 알 수 있었다. 따라서 문헌(Chem . Phram . Bull. 42(9) 1750-1755, 1994)을 검색한 결과 활성물질의 구조는 [화학식 1]의 아나갈로사포닌 IV 로 동정하였다. In order to analyze the structure of the isolated active material, 20 mg of purified No. 4 was dissolved in methanol-d4 and the NMR spectrum was measured. Eight methyl groups were identified in the 1 H NMR spectrum (FIG. 5), and one of them was identified as a methyl group (δ 2.1 ppm, s) connected to an acetyl group. In addition, it was expected that the glycoside form was determined from signals around 5-3.0 ppm. 13C NMR spectrum (Fig. 6) was confirmed from the carbonyl carbon of the acetyl group 172.6ppm 107.3, 105.6, 104.8, and the expected that attached to the glycoside per delayed four into four anomeric carbon at 104.3 per literature (Phytotherapy research , 12, s70-s73, 1998) and 13-C NMR chemical shift. -O- [β-D-xylopyranosyl- (1 → 2) -O-β-D-glucopyranosyl- (1 → 4)]- It was confirmed that the glycoside in the form of [O-β-D-glucopyranosyl- (1 → 2)]-O-α-L-arabinopyranosyl. In addition, it was confirmed that 8 quaternary carbons, 24 CH, 14 CH 2 , and 8 CH 3 in the DEPT spectrum (FIG. 6) showed that the total carbon number of the compound was 54. Excluding the carbon number per 4 from the total carbon number of the compound, the structure of the aglycone having 32 carbon atoms was expected to be a triterpenoid form composed of 5-rings bound by acetyl groups. In addition, the 77.5ppm signal, CH 2 , was moved to the low magnetic field, indicating that the epoxy was bound to oxygen in the ring. Therefore, as a result of searching the literature ( Chem . Phram . Bull . 42 (9) 1750-1755, 1994), the structure of the active substance was identified as Anagalarosponin IV of [Formula 1].

동정된 물질의 분자량을 측정하기 위해 LC-MS/MS 분석을 실시했다. Anagallosaponin IV의 분자량은 1104.57이며 LC-MS/MS 분석결과 소듐이 결합된 형태인 1128.19로 분석되었다. 좀 더 정확한 구조 확인을 위해 MS/MS를 수행한 결과 도 7과 같이 Anagallosaponin Ⅳ 고유의 쪼개짐 패턴을 얻을 수 있었다.LC-MS / MS analysis was performed to determine the molecular weight of the identified material. Anagallosaponin IV had a molecular weight of 1104.57 and was analyzed to be 1128.19 in sodium-bound form by LC-MS / MS analysis. As a result of performing MS / MS for more accurate structure confirmation, it was possible to obtain Anagallosaponin IV-specific cleavage patterns as shown in FIG. 7.

<실시예 4-2> 7번 정제물(G-B-9-7)의 활성물질 동정 - 아나갈로사포닌 Example 4-2 Identification of the Active Substance in Purified Product No. 7 (GB-9-7) -Anagalrosaponin

분리된 활성물질의 구조를 분석하기 위해 7번 정제물 20mg을 메탄올-d4에 녹여 NMR spectrum을 측정하였다. 1H NMR 스펙트럼(도 8)에서 7개의 메틸기를 확인했으며 그 중 하나는 아세틸기에 연결된 메틸기(δ 2.1ppm ,s)임을 확인했다. 또한 5-3.0ppm 부근의 시그널들로 미루어 배당체 형태임을 예상하였다. 13C NMR 스펙트럼(도 9)에서 아세틸기의 카르보닐 탄소 172.6ppm 를 확인하였고 107.4, 104.8, 104.8, 104.3에서 당 4개의 아노머탄소들로 미루어 4개의 당이 배당체로 붙어 있음을 예상하여 문헌(Phytotherapy research, 12, s70-s73, 1998)과 13C NMR chemical shift를 비교한 결과 -O-[β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→4)]-[O-β-D-glucopyranosyl-(1→2)]-O-α-L-arabinopyranosyl 형태의 배당체임을 확인하였다. 13C NMR 스펙트럼을 통해 화합물의 총 탄소수가 54개 임을 예상하였고 화합물 총 탄소수에서 4개당의 탄소수를 제외했을 때 32개의 탄소수를 갖는 아글리콘의 구조는 아세틸 그룹이 결합하고 5환으로 구성된 tirterpenoid 형태로 예상하였다. Anagallosaponin IV와는 달리 23번 메틸기의 13C 28.3ppm 시그널이 사라지고 64.6ppm 시그널이 나타난 것으로 미루어 23번 메틸기에 OH가 결합했음을 예상하였다. 또한 77.5ppm의 시그널로 미루어 epoxy 형태임을 알 수 있었다. 따라서 문헌(Chem . Phram . Bull. 42(9) 1750-1755, 1994)을 검색한 결과 활성물질의 구조는 [화학식 2]의 아나갈로사포닌 Ⅷ로 동정하였다.In order to analyze the structure of the separated active material, 20 mg of purified No. 7 was dissolved in methanol-d4 and NMR spectrum was measured. Seven methyl groups were identified in the 1 H NMR spectrum (FIG. 8), and one of them was identified as a methyl group (δ 2.1 ppm, s) connected to an acetyl group. In addition, it was expected that the glycoside form was determined from signals around 5-3.0 ppm. 13C NMR spectra (Figure 9) were confirmed at the carbonyl carbon of the acetyl group 172.6ppm 107.4, 104.8, 104.8, and the expected that attached to the glycoside per delayed four into four anomeric carbon at 104.3 per literature (Phytotherapy research , 12, s70-s73, 1998) and 13-C NMR chemical shift. -O- [β-D-xylopyranosyl- (1 → 2) -O-β-D-glucopyranosyl- (1 → 4)]- It was confirmed that the glycoside in the form of [O-β-D-glucopyranosyl- (1 → 2)]-O-α-L-arabinopyranosyl. 13C NMR spectra predicted that the total carbon number of the compound was 54, and the structure of the aglycone with 32 carbon atoms, excluding the carbon number per 4 from the total carbon of the compound, was expected to be in the form of tirterpenoids composed of five rings bound by acetyl groups. It was. Unlike Anagallosaponin IV, 13OH 28.3ppm signal disappeared and 64.6ppm signal appeared, suggesting that OH was bound to methyl group 23. In addition, the signal of 77.5ppm showed that the epoxy form. Therefore, as a result of searching the literature ( Chem . Phram . Bull . 42 (9) 1750-1755, 1994), the structure of the active substance was identified as Anagalarosponin 의 of [Formula 2].

동정된 물질의 분자량을 측정하기 위해 LC-MS/MS 분석을 실시했다. 아나갈로사포닌 Ⅷ의 분자량은 1120.57이며 LC-MS/MS 분석결과 소듐이 결합된 형태인 1144.05로 분석되었다. 좀 더 정확한 구조 확인을 위해 MS/MS를 수행한 결과 도 10과 같이 아나갈로사포닌 Ⅷ 고유의 쪼개짐 패턴을 얻을 수 있었다.LC-MS / MS analysis was performed to determine the molecular weight of the identified material. Anagalarosponin VIII had a molecular weight of 1120.57 and was analyzed to be 1144.05 in sodium-bound form by LC-MS / MS analysis. As a result of performing MS / MS to confirm the structure more accurately, it was possible to obtain the cleavage pattern inherent in anagalaroponin Ⅷ as shown in FIG. 10.

<실시예 4-3> 8번 정제물(G-B-9-8)의 활성물질 동정- 아나갈리신 C Example 4-3 Identification of the Active Substances in Purification No. 8 (GB-9-8) -Anagallysin C

분리된 활성물질의 구조를 분석하기 위해 8번 정제물 20mg을 메탄올-d4에 녹여 NMR spectrum을 측정하였다. 1H NMR 스펙트럼(도 11)에서 6개의 메틸기를 확인했다. 또한 5-3.0ppm 부근의 시그널들로 미루어 배당체 형태임을 예상하였다. 또한 앞서 동정한 4, 7번 화합물과 달리 13C NMR 스펙트럼(도 12)에서 아세틸기의 카르보닐 탄소가 관찰되지 않았으며 107.3, 104.7, 104.7, 104.2에서 당 4개의 아노머탄소들로 미루어 4개의 당이 배당체로 붙어 있음을 예상하여 문헌(Phytotherapy research, 12, s70-s73, 1998)과 13C NMR chemical shift를 비교한 결과, -O-[β-D-xylopyranosyl-(1→2)-O-β-D-glucopyranosyl-(1→4)]-[O-β-D-glucopyranosyl-(1→2)]-O-α-L-arabinopyranosyl 형태의 배당체임을 확인하였다. 그리고 13NMR을 통해 화합물의 총 탄소수는 52임을 알 수 있었다. 화합물 총탄소수에서 4개당의 탄소수를 제외했을 때 30개의 탄소수를 갖는 아글리콘의 구조는 tirterpenoid 형태로 예상하였다. 그리고 단일화합물 7번과 동일하게 64.5ppm 시그널을 확인하여 23번 메틸기에 OH가 결합된 형태임을 확인하였고 77.5ppm의 시그널로 미루어 epoxy 형태임을 알 수 있었다. 따라서 문헌(Chem . Phram . Bull. 42(9) 1750-1755, 1994)을 검색한 결과 활성물질의 구조는 아나갈리신 C 로 동정하였다. In order to analyze the structure of the isolated active material, 20 mg of purified No. 8 was dissolved in methanol-d4 and NMR spectrum was measured. Six methyl groups were identified in the 1 H NMR spectrum (FIG. 11). In addition, it was expected that the glycoside form was determined from signals around 5-3.0 ppm. In addition, unlike the compounds 4 and 7 identified above, no carbonyl carbon of the acetyl group was observed in the 13C NMR spectrum (FIG. 12), and 4 sugars were obtained from 4 anomer carbons per 107.3, 104.7, 104.7, and 104.2. In comparison with the expected glycosides ( Phytotherapy research , 12, s70-s73, 1998) and the 13C NMR chemical shift, -O- [β-D-xylopyranosyl- (1 → 2) -O-β It was confirmed that the glycoside in the form of -D-glucopyranosyl- (1 → 4)]-[O-β-D-glucopyranosyl- (1 → 2)]-O-α-L-arabinopyranosyl. 13 NMR showed that the total carbon number of the compound was 52. When the total carbon number of the compound was excluded, the structure of the aglycone having 30 carbon atoms was expected to be in tirterpenoid form. And 64.5ppm signal was confirmed in the same manner as the single compound 7 and the methyl group 23 was confirmed that the OH is bound form, it can be seen that the epoxy form of the 77.5ppm signal. Therefore, as a result of searching the literature ( Chem . Phram . Bull . 42 (9) 1750-1755, 1994), the structure of the active substance was identified as anagalicin C.

동정된 물질의 분자량을 측정하기 위해 LC-MS/MS 분석을 실시했다. 아나갈리신 C의 분자량은 1062.23이며 LC-MS/MS 분석결과 소듐이 결합된 형태인 1086.13으로 분석되었다. 좀 더 정확한 구조 확인을 위해 MS/MS를 수행한 결과 도 13과 같이 아나갈리신 C 고유의 쪼개짐 패턴을 얻을 수 있었다.
LC-MS / MS analysis was performed to determine the molecular weight of the identified material. Anagallysin C had a molecular weight of 1062.23 and was analyzed to be 1086.13 in sodium-bound form by LC-MS / MS analysis. As a result of performing MS / MS to confirm the structure more accurately, it was possible to obtain the cleavage pattern peculiar to analagasin C as shown in FIG. 13.

Claims (9)

갯까치수영 추출물, 갯까치수영 추출물의 분획물, 아나갈로사포닌 Ⅳ, 아나갈로사포닌 Ⅷ 또는 데스글루코나갈로시드 B를 유효성분으로 포함하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물.
Plant disease control composition by magnaporte grisea comprising magpie swimming extract, fractions of magpie swimming extract, angalalo saponin IV, angalalo saponin Ⅷ, or desgluco galloside B as an active ingredient.
제1항에 있어서,
상기 추출물은 물과 에탄올의 혼합 용매에 갯까치수영을 침지시켜 얻어진 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물.
The method of claim 1,
The extract is a plant disease control composition according to Magna Porte Grisce characterized in that obtained by dipping magpie swimming in a mixed solvent of water and ethanol.
제1항에 있어서,
상기 분획물은 하기 (Ⅰ) 및 (Ⅱ) 중 하나인 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물
(Ⅰ) 물과 에탄올의 혼합 용매에 갯까치수영을 침지시켜 얻어진 추출물을 메탄올과 물의 혼합 용매에 현탁시킨 후, 부탄올 또는 헥산으로 분획하여 얻어진 어느 한 용매층의 분획물; 및
(Ⅱ) 물과 에탄올의 혼합 용매에 갯까치수영을 침지시켜 얻어진 추출물을 메탄올과 물의 혼합 용매에 현탁시킨 후 헥산, 디클로로메탄, 에틸아세테이트 및 부탄올을 이용하여 순차적으로 분획하였을 때 얻어지는 헥산층 또는 부탄올층의 분획물.
The method of claim 1,
The fraction is one of the following (I) and (II) plant composition for controlling plant diseases by Magna Porte Grisse
(I) a fraction of any solvent layer obtained by suspending magnolia swimming in a mixed solvent of water and ethanol, suspended in a mixed solvent of methanol and water, and then fractionating with butanol or hexane; And
(II) Hexane layer or butanol obtained when the extract obtained by dipping magpie swimming in a mixed solvent of water and ethanol is suspended in a mixed solvent of methanol and water, and then sequentially fractionated using hexane, dichloromethane, ethyl acetate and butanol. Fractions of layers.
제2항에 있어서,
상기 에탄올과 물의 혼합 용매는 70~90%의 에탄올인 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물.
The method of claim 2,
The mixed solvent of ethanol and water is a plant disease control composition of Magna Porte Grisse, characterized in that 70 to 90% ethanol.
제3항에 있어서,
상기 에탄올과 물의 혼합 용매는 70~90%의 에탄올이고, 상기 메탄올과 물의 혼합 용매는 10~40%의 메탄올인 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물.
The method of claim 3,
The mixed solvent of ethanol and water is 70 to 90% ethanol, and the mixed solvent of methanol and water is 10 to 40% methanol.
제1항에 있어서,
상기 조성물은 농약학적으로 허용 가능한 담체와, 습윤제, 분산제, 부동제, 증점제, 보존제 및 전착제로 구성된 군에서 선택된 하나 이상의 보조제를 추가로 포함하는 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물.
The method of claim 1,
The composition comprises a pesticide acceptable carrier and at least one auxiliary agent selected from the group consisting of wetting agents, dispersants, antifreeze agents, thickeners, preservatives and electrodeposition agents, plant disease control by Magna Porte Grisce Composition.
제1항에 있어서,
상기 조성물은 상기 마그나포르테 그리세아에 의한 식물병은 벼, 잔디, 밀, 보리 또는 피에 발병하는 식물병인 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병 방제제 조성물.

The method of claim 1,
The composition is a plant disease control agent composition according to Magna Porte Grissa, characterized in that the plant disease caused by Magna Porte Grisse is a plant disease affecting rice, grass, wheat, barley or blood.

제1항 내지 제7항 중 어느 한 항 기재의 마그나포르테 그리세아에 의한 식물병 조성물을 식물체에 접촉시키는 단계를 포함하는 마그나포르테 그리세아에 의한 식물병의 방제 방법.
A method for controlling a plant disease by Magnaporte grisea comprising the step of contacting the plant composition with the plant disease composition according to any one of claims 1-7.
제8항에 있어서,
상기 식물체는 벼, 잔디, 보리, 밀 또는 피인 것을 특징으로 하는 마그나포르테 그리세아에 의한 식물병의 방제 방법.

The method of claim 8,
The plant is a rice, grass, barley, wheat or blood method of controlling plant diseases by Magna Porte Grisse, characterized in that.

KR1020100047540A 2010-05-20 2010-05-20 Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea KR101168566B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020100047540A KR101168566B1 (en) 2010-05-20 2010-05-20 Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020100047540A KR101168566B1 (en) 2010-05-20 2010-05-20 Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea

Publications (2)

Publication Number Publication Date
KR20110127980A KR20110127980A (en) 2011-11-28
KR101168566B1 true KR101168566B1 (en) 2012-07-27

Family

ID=45396401

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020100047540A KR101168566B1 (en) 2010-05-20 2010-05-20 Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea

Country Status (1)

Country Link
KR (1) KR101168566B1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101306883B1 (en) 2013-04-24 2013-09-10 남부대학교산학협력단 A composition for control of blast comprising the extract of lysimachiae foenum-graeci herba as an effective component, microcapsule comprising of the same and a control method of blast using the same
KR101306885B1 (en) 2013-04-24 2013-09-10 남부대학교산학협력단 A composition for control of blast comprising the extract of annamorena asphodeloides as an effective component, microcapsule comprising of the same and a control method of blast using the same

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023121331A1 (en) * 2021-12-23 2023-06-29 한국 한의학 연구원 Composition for prevention, amelioration or treatment of respiratory disease containing lysimachia mauritiana extract as active ingredient

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001348305A (en) 2000-06-06 2001-12-18 Hirokazu Shimoji Insecticide
JP2008231016A (en) 2007-03-20 2008-10-02 Noevir Co Ltd External preparation for skin, humectant, anti-ageing agent, antioxidant, anti-inflammatory agent, bleaching agent, and slimming agent
KR100920486B1 (en) 2007-08-24 2009-10-08 한국화학연구원 Composition for controlling plant diseases which comprises neolignan compounds or magnolia spp. plant extract containing them, and method for controlling plant diseases using the same
KR100948332B1 (en) 2008-01-18 2010-03-17 양지화학 주식회사 Composition Comprising the Extracts of Lysimachia clethroides for Prevention and Treatment of Cardiovascular Diseases

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001348305A (en) 2000-06-06 2001-12-18 Hirokazu Shimoji Insecticide
JP2008231016A (en) 2007-03-20 2008-10-02 Noevir Co Ltd External preparation for skin, humectant, anti-ageing agent, antioxidant, anti-inflammatory agent, bleaching agent, and slimming agent
KR100920486B1 (en) 2007-08-24 2009-10-08 한국화학연구원 Composition for controlling plant diseases which comprises neolignan compounds or magnolia spp. plant extract containing them, and method for controlling plant diseases using the same
KR100948332B1 (en) 2008-01-18 2010-03-17 양지화학 주식회사 Composition Comprising the Extracts of Lysimachia clethroides for Prevention and Treatment of Cardiovascular Diseases

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101306883B1 (en) 2013-04-24 2013-09-10 남부대학교산학협력단 A composition for control of blast comprising the extract of lysimachiae foenum-graeci herba as an effective component, microcapsule comprising of the same and a control method of blast using the same
KR101306885B1 (en) 2013-04-24 2013-09-10 남부대학교산학협력단 A composition for control of blast comprising the extract of annamorena asphodeloides as an effective component, microcapsule comprising of the same and a control method of blast using the same

Also Published As

Publication number Publication date
KR20110127980A (en) 2011-11-28

Similar Documents

Publication Publication Date Title
AU639058B2 (en) Method and compositions for stimulating vesicular-arbuscular mycorrhizal fungi
Kroschel et al. Pathogenicity of fungi collected in northern Ghana to Striga hermonthica
US8435571B2 (en) Extracts and compounds from “Agapanthus africanus” and their use as biological plant protecting agents
KR20190054871A (en) Composition for controlling plant diseases including Trevesia palmata, fraction of thereof or a compound isolated therefrom as an active ingredient and method of controlling plant diseases using the same
KR101168566B1 (en) Compostion and Method for Controling Plant Disease Occurred by Magnaporthe grisea
KR101802911B1 (en) Composition for controlling root knot nematode comprising kojic acid as effective component and uses thereof
Bulman et al. Needle diseases of radiata pine in New Zealand
KR940010036B1 (en) Process for preparing macrocyclic compound
KR101249854B1 (en) Composition and Method for Controlling Plant Disease Occurred by Magnaporthe grisea Using a Fruit Extract of Pittosporum tobira Ait or Saponin ⅢA3 Isolated from the Fruit Extract
Børve et al. Colletotrichum acutatum overwinters on sweet cherry buds
KR101168567B1 (en) Composition and Method for Controling Post-harvest Disease of Citrus Fruit or Sweet Potato
KR102653110B1 (en) Composition for controlling plant diseases comprising Boesenbergia pulcherrima extract
HU209950B (en) Microbiological process for producing agriculturally acceptable active ingredients and fungicid composition containing them
KR101482322B1 (en) Composition containing extracts of Streptomyces for preventing Xanthomonas spp.
KR20130109646A (en) Composition and method for controlling plant disease caused by rhizoctonia cerealis or rhizoctonia solani using an extract of albizzia julibrissin
KR101478410B1 (en) Composition containing extracts of Streptomyces for preventing Xanthomonas spp.
Pohronezny et al. 386 Vol. 61, No. 5--PLANT DISEASE REPORTER--May 1977 FIELD STUDIES OF YIELD LOSSES IN PICKLING CUCUMBER DUE TO ANGULAR LEAFSPOT
KR101534827B1 (en) A composition for preventing sheath blight of rice containing an extract of ginkgo spermoderm
KR100809797B1 (en) Composition for control anthracnose with extracts and isolated compound from roots of agrimonia pilosa l
KR100634866B1 (en) Novel ulocladium atrum cnu 9055, plant fungal diseases controlling compositions using the fungus and control method using the compositions
KR101541213B1 (en) Composition containing extracts of Streptomyces for preventing Xanthomonas spp.
US20230073101A1 (en) Microalgal extracellular polymeric substances and agricultural uses thereof
KR101249850B1 (en) Composition and Method for Controling Post-harvest Disease of Citrus Fruit or Sweet Potato Using a Fruit Extract of Pittosporum tobira Ait or Saponin ⅢA3 Isolated from the Fruit Extract
Ellis et al. Movement of methyl 2-benzimidazolecarbamate into soybean seeds after foliar application of benomyl
KR20170041954A (en) Composition Including Ginko Seed Scarcotesta Extract for Disinfecting Rice Seeds to Prevent the Bakanae Disease of Rice (Gibberella fujikuroi)

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20150709

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20160712

Year of fee payment: 5

FPAY Annual fee payment

Payment date: 20170627

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20180625

Year of fee payment: 7